119 related articles for article (PubMed ID: 7830846)
1. Antithrombin III concentrate in the treatment of DIC: a retrospective follow-up study.
van Beek EJ; von der Möhlen MA; ten Cate JW; Brandjes DP; Büller HR
Neth J Med; 1994 Nov; 45(5):206-10. PubMed ID: 7830846
[TBL] [Abstract][Full Text] [Related]
2. Effects of antithrombin III in patients with disseminated intravascular coagulation diagnosed by newly developed diagnostic criteria for critical illness.
Sawamura A; Gando S; Hayakawa M; Hoshino H; Kubota N; Sugano M
Clin Appl Thromb Hemost; 2009 Oct; 15(5):561-6. PubMed ID: 18840625
[TBL] [Abstract][Full Text] [Related]
3. Antithrombin III concentrates for treatment of disseminated intravascular coagulation in children.
Hanada T; Abe T; Takita H
Am J Pediatr Hematol Oncol; 1985; 7(1):3-8. PubMed ID: 4037242
[TBL] [Abstract][Full Text] [Related]
4. [Substitution of antithrombin III in shock patients].
Blauhut B; Necek S; Vinazzer H; Bergmann H
Anaesthesist; 1982 Jul; 31(7):349-52. PubMed ID: 7125179
[TBL] [Abstract][Full Text] [Related]
5. Differences in antithrombin III activities by administration method in critical patients with disseminated intravascular coagulation: a pharmacokinetic study.
Aibiki M; Fukuoka N; Nishiyama T; Maekawa S; Shirakawa Y
Shock; 2007 Aug; 28(2):141-7. PubMed ID: 17515857
[TBL] [Abstract][Full Text] [Related]
6. First day dynamic changes in antithrombin III activity after supplementation have a predictive value in critically ill patients.
Gando S; Sawamura A; Hayakawa M; Hoshino H; Kubota N; Oshiro A
Am J Hematol; 2006 Dec; 81(12):907-14. PubMed ID: 16924643
[TBL] [Abstract][Full Text] [Related]
7. [Place of antithrombin III concentrate in the intensive care of disseminated intravascular coagulation].
Vorob'eva NA; Neporada EL; Turundaevskaia OV; Mel'nikova GN
Anesteziol Reanimatol; 2007; (2):42-4. PubMed ID: 17563999
[TBL] [Abstract][Full Text] [Related]
8. Activity-guided antithrombin III therapy in severe surgical sepsis: efficacy and safety according to a retrospective data analysis.
Moubarak P; Zilker S; Wolf H; Hofner B; Kneib T; Küchenhoff H; Jauch KW; Hartl WH
Shock; 2008 Dec; 30(6):634-41. PubMed ID: 18520701
[TBL] [Abstract][Full Text] [Related]
9. Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart review.
Lorente L; Jiménez A; Palmero S; Jiménez JJ; Iribarren JL; Santana M; Martín MM; Mora ML
Clin Ther; 2007 Nov; 29(11):2433-9. PubMed ID: 18158083
[TBL] [Abstract][Full Text] [Related]
10. [Studies on antithrombin III. II. The role for antithrombin III (ATIII) in the control of disseminated intravascular coagulation (DIC). (The effect of the administration of ATIII concentrates in experimental DIC and in clinical DIC) (author's transl)].
Takahashi K
Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):889-97. PubMed ID: 6940410
[No Abstract] [Full Text] [Related]
11. High dose of intravenous antithrombin III without heparin in the treatment of disseminated intravascular coagulation and organ failure in four children.
Fuse S; Tomita H; Yoshida M; Hori T; Igarashi C; Fujita S
Am J Hematol; 1996 Sep; 53(1):18-21. PubMed ID: 8813091
[TBL] [Abstract][Full Text] [Related]
12. [Fundamental studies on the management of disseminated intravascular coagulation (DIC) with antithrombin III (AT-III) concentrate].
Gotoh K
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Apr; 37(4):571-80. PubMed ID: 3989338
[TBL] [Abstract][Full Text] [Related]
13. Is continuous infusion ceftriaxone better than once-a-day dosing in intensive care? A randomized controlled pilot study.
Roberts JA; Boots R; Rickard CM; Thomas P; Quinn J; Roberts DM; Richards B; Lipman J
J Antimicrob Chemother; 2007 Feb; 59(2):285-91. PubMed ID: 17135183
[TBL] [Abstract][Full Text] [Related]
14. [Coagulation tests in septic surgical patients].
Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
[TBL] [Abstract][Full Text] [Related]
15. [Anti-coagulant therapy--antithrombin III].
Tsuji H
Rinsho Ketsueki; 1990 Jun; 31(6):750-5. PubMed ID: 2214165
[TBL] [Abstract][Full Text] [Related]
16. The acute physiology and chronic health evaluation III outcome prediction in patients admitted to the intensive care unit after pneumonectomy.
Keegan MT; Harrison BA; Brown DR; Whalen FX; Cassivi SD; Afessa B
J Cardiothorac Vasc Anesth; 2007 Dec; 21(6):832-7. PubMed ID: 18068061
[TBL] [Abstract][Full Text] [Related]
17. Non-overt disseminated intravascular coagulation scoring for critically ill patients: the impact of antithrombin levels.
Egi M; Morimatsu H; Wiedermann CJ; Tani M; Kanazawa T; Suzuki S; Matsusaki T; Shimizu K; Toda Y; Iwasaki T; Morita K
Thromb Haemost; 2009 Apr; 101(4):696-705. PubMed ID: 19350114
[TBL] [Abstract][Full Text] [Related]
18. Thrombocytopenia in sepsis: a predictor of mortality in the intensive care unit.
Lee KH; Hui KP; Tan WC
Singapore Med J; 1993 Jun; 34(3):245-6. PubMed ID: 8266183
[TBL] [Abstract][Full Text] [Related]
19. Reduction of mortality with antithrombin III in septicemic rats: a study of Klebsiella pneumoniae induced sepsis.
Dickneite G; Pâques EP
Thromb Haemost; 1993 Feb; 69(2):98-102. PubMed ID: 8456437
[TBL] [Abstract][Full Text] [Related]
20. The usefulness of antithrombin activity monitoring during antithrombin supplementation in patients with sepsis-associated disseminated intravascular coagulation.
Iba T; Saitoh D; Gando S; Thachil J
Thromb Res; 2015 May; 135(5):897-901. PubMed ID: 25784136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
